Hakutulokset - Evandro de Azambuja

Improving the adjuvant treatment of HER2-positive breast cancer: APHINITY and ExteNET trials Tekijä Noam Pondé, Evandro de Azambuja

Hae kokoteksti

Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely? Tekijä Elisa Agostinetto, Luca Arecco, Evandro de Azambuja

Hae kokoteksti

Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer Tekijä Elisa Agostinetto, Evandro de Azambuja, Matteo Lambertini

Hae kokoteksti

Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA. Tekijä Felipe Ades, Christelle Senterre, Dimitrios Zardavas, Evandro de Azambuja, Razvan Popescu, Martine Piccart

Hae kokoteksti

Intraoperative breast cancer margin evaluation using fluorescence imaging with intravenous injection of indocyanine green (BREASTIFLU-1): study protocol for a randomized diagnostic... Tekijä C. Florin Pop, Isabelle Veys, Michel Moreau, Marianne Paesmans, Evandro De Azambuja, Denis Larsimont, Gabriel Liberale

Hae kokoteksti

Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment Tekijä Guilherme Nader-Marta, Chiara Molinelli, Véronique Debien, Diogo Martins-Branco, Philippe Aftimos, Evandro de Azambuja, Ahmad Awada

Hae kokoteksti

Brazilian medical oncologists: current and future perspectives for 2020 Tekijä Júlia Plentz Portich, Juliana Giacomazzi, Alessandra Menezes Morelle, Daniela Dornelles Rosa, José Roberto Freitas Rossari, Evandro de Azambuja

Hae kokoteksti

Medication Guide: A web application for personalized benefit-risk assessments of OTC analgesics Tekijä Philipp Lampert, Evandro de Azambuja, Juan Manuel Escalona Rosales, Jennifer von Stebut-Marx, Jakob Fenske, Carsten Rendenbach, Reinhold Kreutz

Hae kokoteksti

Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapy Tekijä C. Florin Pop, Clémence Ortega, Mathilde Lecomte, Paulus Kristanto, Chirine Khaled, Filip De Neubourg, Antoine Desmet, Evandro De Azambuja, Denis Larsimont, Isabelle Veys

Hae kokoteksti

Antibody–drug conjugates in patients with advanced/metastatic HER2-low-expressing breast cancer: a systematic review and meta-analysis Tekijä Isabella Michelon, Maria Inez Dacoregio, Maysa Vilbert, Jonathan Priantti, Caio Ernesto do Rego Castro, Lucas Vian, Paolo Tarantino, Evandro de Azambuja, Ludimila Cavalcante

Hae kokoteksti

Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer Tekijä Soraia Lobo-Martins, Diogo Martins-Branco, Francine Padonou, Hafid Dahma, Sigi van den Wijngaert, Mounia Jaouart, Chiara Dauccia, Chiara Dauccia, Chiara Molinelli, Chiara Molinelli, Chiara Molinelli, Elisa Agostinetto, Angela Loizidou, Donatienne Taylor, Anais Boisson, Soizic Garaud, Chloé Spilleboudt, Jose Vicente Cardona, Peter Ramge, Bogdana Ioana Balas, Mohammed Bajji, Fanny George, Tabatha Delsaute, Marianne Paesmans, Lieveke Ameye, Martine Piccart, Evandro de Azambuja, Evandro de Azambuja, Karen Willard-Gallo

Hae kokoteksti

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer Tekijä Tamar Zahavi, Mali Salmon-Divon, Roberto Salgado, Michael Elkin, Esther Hermano, Ariel M. Rubinstein, Prudence A. Francis, Angelo Di Leo, Giuseppe Viale, Evandro de Azambuja, Lieveke Ameye, Christos Sotiriou, Asher Salmon, Nataly Kravchenko-Balasha, Amir Sonnenblick

Hae kokoteksti

Understanding Barriers to Clinical Trial Participation Among Cancer Patients: Insights from a Brazilian Oncology Center Tekijä Erika Bushatsky Andrade de Alencar, Ana Beatriz Nery Faria de Paiva, Andressa Liz Cândido, Rafaela Maria Sant'Anna Paiola, Alessandra Cristina Machado Barata Tavares, Evandro de Azambuja, Felipe José Silva Melo Cruz, Lilian Arruda do Rêgo Barros

Hae kokoteksti

Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysis Tekijä Chiara Dauccia, Marco Bruzzone, Luca Arecco, Eva Blondeaux, Marianna Sirico, Riccardo Gerosa, Maria Alice Franzoi, Mariana Brandão, Lorenzo Perrone, Paolo Pedrazzoli, Christine Desmedt, Serena Di Cosimo, Claudio Vernieri, Laetitia Collet, Matteo Lambertini, Evandro de Azambuja, Elisa Agostinetto

Hae kokoteksti

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer Tekijä Elisa Agostinetto, Lieveke Ameye, Samuel Martel, Philippe Aftimos, Noam Pondé, Christian Maurer, Sarra El-Abed, Yingbo Wang, Malou Vicente, Saranya Chumsri, Judith Bliss, Judith Kroep, Marco Colleoni, Fausto Petrelli, Lucia Del Mastro, Alvaro Moreno-Aspitia, Martine Piccart, Marianne Paesmans, Evandro de Azambuja, Matteo Lambertini

Hae kokoteksti

Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study Tekijä Karen Van Baelen, Ha-Linh Nguyen, François Richard, Gitte Zels, Maria Margarete Karsten, Guilherme Nader-Marta, Peter Vermeulen, Luc Dirix, Adam David Dordevic, Evandro de Azambuja, Denis Larsimont, Marion Maetens, Elia Biganzoli, Hans Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Giuseppe Floris, Christine Desmedt

Hae kokoteksti

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer. Tekijä Michail Ignatiadis, Dimitrios Zardavas, Marc Lemort, Celine Wilke, Marie-Catherine Vanderbeeken, Veronique D'Hondt, Evandro De Azambuja, Andrea Gombos, Fabienne Lebrun, Lissandra Dal Lago, Fanny Bustin, Marion Maetens, Lieveke Ameye, Isabelle Veys, Stefan Michiels, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Jean-Marie Nogaret, Martine Piccart, Ahmad Awada

Hae kokoteksti

Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysis Tekijä Luca Arecco, Pedro M. Cacilhas, Camila Bobato Lara Gismondi, Marco Bruzzone, Gabriella Gentile, Riccardo Gerosa, Eva Blondeaux, Elisa Agostinetto, Chiara Dauccia, Soraia Lobo-Martins, Rafael Grochot, Kamal S. Saini, Hatem A. Azim, Jr., Marcio Debiasi, Alex De Caluwé, Laurence Buisseret, Lucia Del Mastro, Matteo Lambertini, Evandro de Azambuja

Hae kokoteksti

Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study Tekijä Luca Arecco, Maria Maddalena Latocca, Eva Blondeaux, Ferdinando Riccardi, Carmela Mocerino, Valentina Guarneri, Eleonora Mioranza, Giancarlo Bisagni, Elisa Gasparini, Fabio Puglisi, Alexandro Membrino, Antonella Ferro, Vincenzo Adamo, Filippo Giovanardi, Stefano Tamberi, Sara Donati, Elisabetta Landucci, Laura Biganzoli, Sara Piccinini, Simona Pastorino, Evandro de Azambuja, Francesca Poggio, Matteo Lambertini, Lucia Del Mastro

Hae kokoteksti

Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109) Tekijä Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, Angela DeMichele, Paolo Tarantino, Evandro de Azambuja, Georg Pfeiler, Miguel Martin, Justin M. Balko, Zbigniew Nowecki, Marija Balic, Adam M. Brufsky, Arlene Chan, Patrick G. Morris, Tufia Haddad, Sibylle Loibl, Yuan Liu, Lidija Soelkner, Christian Fesl, Erica L. Mayer, Michael Gnant, on behalf of the PALLAS groups and investigators

Hae kokoteksti